Table 1 Patients characteristics from published EVAR series with renal CG
Reference | Patients | Mean age (years) | Gender | Body Mass Index | Aortic disease | Follow-up (months) |
|---|---|---|---|---|---|---|
Ullery BW 2017 [5] | 15 | 75.8 ± 7.7 | 12 M; 3F | 27.5 ± 9.5 | AAA | 25.5 |
Sugimoto M 2017 [6] | 38 | 75 ± 8.1 | 34 M; 4F | – | AAA | 12 |
Caradu C 2017 [7] | 26 | 74.7 ± 6.9 | 24 M; 2F | 4 with BMI > 30 | composite | 20 (range:1–35) |
Youssef M 2017 [8] | 10 | – | – | – | failed EVAR | 8 (range:3–24) |
De Bruin JL 2016 [9] | 28 | 75 (range:60–87) | 22 M; 6F | – | JAA | 4 |
Ronchey S 2015 [10] | 20 | 76.1 ± 4.6 | 16 M; 4F | – | AAA | 30.9 ± 20.6 (range:5–58) |
XiaoHui M 2015 [11] | 42 | 71 ± 7.0 | 35 M; 7F | – | JAA | 26 ± 13 (range:6–64) |
Scali ST 2014 [12] | 41 | 73 ± 8.0 | 27 M; 14F | 26 ± 7 | JAA; AAA; failed EVAR | 18.2 (range:1.4–41.5) |
Ducasse E 2014 [13] | 22 | 73 (range:63–88) | 21 M; 1F | – | JAA | 18 (range:7–35) |
Tolenaar JL 2013 [14] | 12 | 77.2 ± 6.2 | 11 M; 1F | – | AAA; failed EVAR | 10.8 (range:7.4–19.4) |
Bin Jabr A 2013 [15] | 10 | 68 ± 4.7 | 0 M; 10F | – | aortic stenosis or occlusion | 33.1 ± 25.7 |
Lee JT 2012 [16] | 27 | 74.8 ± 6.5 | 19 M; 8F | – | AAA; failed EVAR | 10.6 ± 7.5 (range:3–25) |
Donas KP 2012 [17] | 30 | 74.5 ± 7.3 | 27 M; 3F | – | AAA | 15.2 ± 6.2 |
Coscas R 2011 [18] | 13 | 74.8 ± 7.6 | 11 M; 2F | – | JAA | 10.5 ± 5.5 |
Bruen KJ 2011 [19] | 21 | 72 ± 8.0 | 11 M; 10F | – | JAA | 12 |
Donas KP 2010 [20] | 15 | 81.8 | 15 M; 0F | – | AAA | 6.8 ± 3.3 (range:1–13) |
Ullery BW [21] | 60 | 75.8 ± 7.6 | 42 M; 18F | – | JAA; AAA; failed EVAR; Type IV TAAA | 20.1 ± 21.0 |
Total | 430 | 74.5 ± 2.9 | 327 M; 93F; 10 undisclosed | – | – | 16.5 ± 8.5 |